scholarly journals Nonpreserved amniotic membrane transplantation for bilateral toxic keratopathy caused by topical anesthetic abuse: a case report

2010 ◽  
Vol 4 (1) ◽  
Author(s):  
Ayse Asyali Altinok ◽  
Melike Balikoglu ◽  
Emine Sen ◽  
Kurtulus Serdar
Keyword(s):  
Case Report ◽  
Amniotic Membrane ◽  
Amniotic Membrane Transplantation ◽  
Topical Anesthetic ◽  
Toxic Keratopathy

scholarly journals Stabilization of Bilateral Progressive Rheumatoid Corneal Melt with Infliximab

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Sheelah F. Antao ◽  
Tariq Ayoub ◽  
Hasan Tahir ◽  
Dipak N. Parmar
Keyword(s):  
Rheumatoid Arthritis ◽  
Case Report ◽  
Amniotic Membrane ◽  
Conventional Treatment ◽  
Penetrating Keratoplasty ◽  
Amniotic Membrane Transplantation ◽  
Cyanoacrylate Glue ◽  
Ocular Discomfort ◽  
History Of ◽  
Ulcerative Keratitis

Purpose. To report the use of infliximab in the rapid stabilization of a case of progressive, bilateral rheumatoid peripheral ulcerative keratitis (PUK) that failed to respond to conventional immunosuppressive therapy.Methods. A single interventional case report.Results. A patient with rheumatoid arthritis presented with bilateral PUK following a 2-month history of ocular discomfort and redness. His systemic prednisolone (PDN) and methotrexate (MTX) were increased and, despite an initial favorable response, bilateral recurrent corneal perforations ensued. Both eyes underwent cyanoacrylate glue repair, amniotic membrane transplantation (AMT), and penetrating keratoplasty (PKP). Recurrence of the disease and bilateral perforations of the second PKP in both eyes prompted administration of intravenous infliximab immediately after the fourth PKP. The disease activity rapidly settled in both eyes, and at eighteen-month followup, after 12 infliximab infusions, the PUK remains quiescent with no further graft thinning or perforation.Conclusion. Infliximab can be used to arrest the progression of severe bilateral rheumatoid PUK in cases that are refractory to conventional treatment.

scholarly journals Evaluation of Plasma-Assisted Noninvasive Surgery (PANIS) as a New Technique for Sublimating Large Benign Conjunctival Nevus with Amniotic Membrane Transplantation (AMT); A Clinical Case Report

2021 ◽  
Author(s):  
Farhad Nejat ◽  
Khosrow Jadidi ◽  
Shima Eghtedari ◽  
Maryam Moradi ◽  
Nazanin Sadat Nabavi
Keyword(s):  
Case Report ◽  
Amniotic Membrane ◽  
Therapeutic Option ◽  
Amniotic Membrane Transplantation ◽  
Surgical Removal ◽  
Ocular Surface Disease Index ◽  
Noninvasive Surgery ◽  
Ocular Lesions ◽  
History Of ◽  
A New Technique

Abstract Background: conjunctival nevi are benign ocular lesions with a low risk of malignant transformation to melanoma. Due to cosmetic reasons patients usually consider surgical removal options. In this case report, we are presenting a new approach using plasma-assisted noninvasive surgery (PANIS) with amniotic membrane transplantation (AMT) to sublimate the nevus border and fuse the AMT with the remaining conjunctiva.Case presentation: A 33-year-old man with a history of large conjunctival nevus in his left eye, that its benignity was proved by an expert ophthalmologist through years of examination, has visited our center in September 2020. Plasma spots were used to sublimate the nevus border and fuse AMT with the conjunctiva. The patient was discharged fully satisfied without any complications and no recurrences were seen in a year of follow-up. Visual parameters were not significantly changed while the Ocular Surface Disease Index (OSDI) was reduced dramatically. Conclusion: Conjunctival nevi removal using the PANIS method with AMT is a safe, minimally invasive, and inexpensive therapeutic option. Plasma spots are suitable for AMT adhesion to the remaining conjunctiva after the nevus removal.

scholarly journals Managing Drawbacks in Unconventional Successful Glaucoma Surgery: A Case Report of Stent Exposure

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Antonio Fea ◽  
Paola Maria Loredana Cannizzo ◽  
Giulia Consolandi ◽  
Carlo Alessandro Lavia ◽  
Giulia Pignata ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Case Report ◽  
Amniotic Membrane ◽  
Complication Rate ◽  
Glaucoma Surgery ◽  
Amniotic Membrane Transplantation ◽  
Exposed Area ◽  
Shunt Implantation

Traditional options in managing failed trabeculectomy (bleb needling, revision, additional incisional surgery and tube surgery) have a relatively high failure and complication rate. The use of microinvasive glaucoma surgery (MIGS) has generally been reserved to mild to moderate glaucoma cases, proving good safety profiles but significant limitations in terms of efficacy. We describe a patient who underwent MIGS (XEN Aquesys subconjunctival shunt implantation) after a prior failed trabeculectomy. After the surgery, the IOP was well controlled but as the stent was close to an area of scarred conjunctiva of the previous trabeculectomy, it became partially exposed. As a complete success was achieved, we decided to remove the conjunctiva over the exposed area and replace it by an amniotic membrane transplantation and a conjunctiva autograft. Six months after surgery, the unmedicated IOP is still well controlled with complete visual acuity recovery.

scholarly journals Management of a case of symblepharon by freshly prepared amniotic membrane transplantation: a clinical case report

2020 ◽  
Vol 8 (8) ◽  
pp. 3074
Author(s):  
Mamoni Baruah ◽  
Rajiv Kr. Das ◽  
Bikram Dam ◽  
Sunanda Nandi
Keyword(s):  
Case Report ◽  
Amniotic Membrane ◽  
Clinical Case ◽  
Therapeutic Use ◽  
Cosmetic Result ◽  
Amniotic Membrane Transplantation ◽  
Ocular Disorders

Amniotic membrane transplantation has been in common therapeutic use for a variety of ocular disorders. Authors present a case of a 50-year-old man who was diagnosed to be a case of total symblepharon following an episode of membranous conjunctivitis who was treated with freshly prepared Amniotic membrane transplantation with satisfactory cosmetic result.

Use of Amniotic Membrane Transplantation in Isolated Conjunctival Bowen Disease: A Case Report

2010 ◽  
Vol 20 (3) ◽  
pp. 604-607 ◽  
Author(s):  
Ilaria Motolese ◽  
Luigi Mazzera ◽  
Paolo Frezzotti ◽  
Paolo Alfonso Motolese ◽  
Eduardo Motolese
Keyword(s):  
Case Report ◽  
Amniotic Membrane ◽  
Amniotic Membrane Transplantation ◽  
Bowen Disease

scholarly journals Hypopyon after Primary Cryopreserved Amniotic Membrane Transplantation for Sterile Corneal Ulceration: A Case Report and Review of the Literature

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Kostas G. Boboridis ◽  
Dimitrios G. Mikropoulos ◽  
Nick S. Georgiadis
Keyword(s):  
Case Report ◽  
Amniotic Membrane ◽  
Topical Treatment ◽  
Rare Complication ◽  
Amniotic Membrane Transplantation ◽  
Ocular Infection ◽  
Eye Drops ◽  
Corneal Surface ◽  
Corneal Epithelial ◽  
Corneal Epithelial Defect

Purpose. To report the acute development of hypopyon after primary cryopreserved amniotic membrane transplantation (AMT) for persistent corneal epithelial defect and sterile ulceration. Case Presentation. A selected case report of a 71-year-old male who underwent primary cryopreserved AMT for the management of long-standing corneal epithelial defects and stroma thinning. The patient developed 2 mm sterile hypopyon within 48 hours after AMT for corneal surface reconstruction. He responded well to the intensified routine postoperative topical treatment of steroid and antibiotic eye drops with the hypopyon resolving completely one week later. Five weeks after surgery, the corneal surface was smooth and epithelialized with no anterior chamber reaction or recurrence of hypopyon. Discussion. Hypopyon may develop as a rare complication of primary cryopreserved AMT for sterile corneal defects. It may be attributed to immunologic or hypersensitivity reaction and should be differentiated from active ocular infection as it resolves spontaneously with the routine postoperative topical treatment of steroid and antibiotic drops.

Sign in / Sign up

Export Citation Format

Share Document